Table 1.

Distribution of TRIM29 in bladder cancer according to clinicopathological characteristics

Characteristic	No. of patients	TRIM29 negative	TRIM29 overexpression	p-value
Age (yr)
< 60	43	21	22	0.221
≥ 60	59	36	23
Sex
Male	73	42	31	0.594
Female	29	15	14
Tumor status
Ta-T1	60	40	20	0.009
T2-T4	42	17	25
Tumor grade
G1	47	29	18	0.274
G2 and G3	55	28	27